LZTR1: A Protein Involved in Disease Development and Tissue Homeostasis

Target Name: LZTR1

NCBI ID: G8216

LZTR1

LZTR1: A Protein Involved in Disease Development and Tissue Homeostasis

LZTR1 (TCFL2) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the transforming growth factor beta (TGF-β) family, which is known for their role in cell growth, differentiation, and repair. LZTR1 has been shown to play a role in the development and progression of a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, LZTR1 has become a focus of interest for researchers studying these conditions and for the development of new treatments.

One of the key features of LZTR1 is its ability to interact with other proteins, particularly with the transcription factor p53. p53 is a well-known protein that is involved in the regulation of gene expression and has been implicated in many diseases, including cancer. LZTR1 has been shown to physically interact with p53 and can modulate its activity. This interaction between LZTR1 and p53 raises the possibility that LZTR1 may be a drug target or biomarker for diseases that are characterized by the over-expression or dysfunction of p53.

Another potential mechanism by which LZTR1 may be involved in the development of disease is its role in the regulation of cellular processes that are critical for maintaining tissue homeostasis. LZTR1 has been shown to play a role in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. This regulation is important for maintaining the structure and function of tissues and is critical for the development and maintenance of organs. LZTR1 dysfunction has been implicated in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its role in cell adhesion and regulation of p53, LZTR1 has also been shown to play a role in the regulation of cellular processes that are critical for the development and maintenance of tissues and organs. LZTR1 has been shown to be involved in the regulation of cell proliferation, migration, and the formation of tissues and organs. This regulation is important for the development and maintenance of tissues and organs and is critical for the development and maintenance of organisms. LZTR1 dysfunction has been implicated in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The potential clinical applications of LZTR1 are significant. LZTR1 dysfunction has been implicated in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a drug target or biomarker, LZTR1 may be used to develop new treatments for these diseases. For example, LZTR1 has been shown to be involved in the regulation of cell adhesion and p53 function, which suggests that it may be a useful target for drugs that target these processes. In addition, LZTR1 dysfunction has been implicated in the regulation of cell proliferation and migration, which suggests that it may be a useful target for drugs that target these processes. The development of small molecules or other compounds that can modulate LZTR1 function may therefore have significant clinical applications.

In conclusion, LZTR1 is a protein that has been shown to play a role in the development and progression of a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its interaction with the transcription factor p53 and its ability to regulate cellular processes that are critical for tissue homeostasis and development and maintenance raise the possibility of LZTR1 as a drug target or biomarker. Further research is needed to fully understand the role of LZTR1 in disease and to develop new treatments based on its properties.

Protein Name: Leucine Zipper Like Transcription Regulator 1

Functions: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex that mediates ubiquitination of Ras (K-Ras/KRAS, N-Ras/NRAS and H-Ras/HRAS) (PubMed:30442762, PubMed:30442766, PubMed:30481304). Is a negative regulator of RAS-MAPK signaling that acts by controlling Ras levels and decreasing Ras association with membranes (PubMed:30442762, PubMed:30442766, PubMed:30481304)

The "LZTR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LZTR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets